For too long,” he recently told a meeting of generals and admirals flown in from around the world to hear him speak, “the ...
The discovery could significantly reduce the production costs of fuels, chemicals, and materials. A research team from the ...
Efficacy of tirzepatide does not differ significantly between men and women, despite sex-specific differences in ...
There are questions about who TrumpRx really benefits. The Washington Post reported that it may benefit BlinkRx, an online ...
President Trump said at Thursday's cabinet meeting that the deal with Pfizer to give the U.S. "most favored nation" status ...
The United Nations will begin slashing its peacekeeping force and operations, forcing thousands of soldiers in the next ...
Recent advancements in medical therapy for heart failure with mildly reduced ejection fraction (HFmrEF) or preserved ejection ...
Finally this week, TORL BioTherapeutics completed a $96 million Series C that will be deployed in the development of its lead ...
The American College of Cardiology is launching a new program to educate clinicians on the latest advances, medications and ...
Pharmaceutical Technology on MSN

NanoPhoria raises $98m to develop HFrEF treatment

Italy-based biotech firm NanoPhoria Bioscience has announced the initial closing of its Series A funding round, raising ...